Compare Novo Nordisk A/S (NVO) vs Vital Farms Inc (VITL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Vital Farms Inc — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Vital Farms Inc trades at $13.16 (market cap $590.45M). The key difference: Novo Nordisk A/S is far larger — about 373.5× Vital Farms Inc's market cap, and Novo Nordisk A/S pays a 3.63% dividend while Vital Farms Inc pays none. Which is the better fit depends on your goals.
| NVO | VITL | |
|---|---|---|
Market Cap | $220.53B | $590.45M |
Sector | Health | Consumer Staples |
52-Week High | $71.70 | $52.41 |
52-Week Low | $35.29 | $8.28 |
Enterprise Value | $239.49B | $593.26M |
Dividend Yield | 3.63% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Vital Farms Inc
Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →
